HCWB Stock Soars 82% on Breakthrough Cancer Therapy Results
-
最新报道：HCW Biologics (NASDAQ: HCWB) surged 82.23% to $6.05 in premarket trading after announcing positive non-human primate study results for its second-generation T-cell engager program. The therapy demonstrated strong safety and efficacy against solid tumors like pancreatic cancer and glioblastoma, with no cytokine release syndrome observed. CEO Dr. Hing C. Wong highlighted 100% survival in preclinical mouse models. The stock, previously near its 52-week low of $2.77, saw heavy trading volume amid optimism for its cancer immunotherapy potential.
下一篇
Why is Warner Bros Discovery Stock Soaring Today?
- Warner Bros Discovery (WBD) shares surged over 30% on September 12, 2025, following report...
24小时热点
热点专题
418041